🔍

NAVINFLUOR - Navin Fluo.Intl.

📊 NSE: NAVINFLUOR 🏢 Chemicals 📅 Last Updated: 12/14/2025 10:21

📢 Recent Corporate Announcements

Navin Fluorine Schedules Q4 & FY26 Earnings Call for April 29, 2026

🟡 NEUTRAL ⭐ 4/10

EARNINGS 📅 22 Apr 2026, 07:45 PM

Navin Fluorine International Limited has announced its earnings conference call for the quarter and financial year ended March 31, 2026, scheduled for April 29, 2026, at 6:30 PM IST. The management team, including the Chairman, Managing Director, and CFO, will discuss the company's operational and financial performance. This call is a standard procedure for investors to gain insights into the company's fiscal health and strategic direction following the end of the 2025-26 financial year. Pre-registration is available for participants to join the discussion via the provided link.

Earnings call scheduled for April 29, 2026, at 6:30 PM IST
Agenda includes discussion of Q4 and full FY 2025-26 financial results
Top management including Chairman Vishad Mafatlal and MD Nitin Kulkarni to participate
International dial-in facilities provided for HK, Singapore, USA, and UK investors

💡 Investors should monitor the call for management's commentary on specialty chemical demand and margin outlook. It is a key event to assess the company's performance against market expectations for the fiscal year.

Navin Fluorine Allots 37,385 Equity Shares Under ESOP 2017

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 21 Apr 2026, 06:00 PM

Navin Fluorine International Limited has allotted 37,385 equity shares of face value ₹2 each to eligible employees on April 21, 2026. This allotment follows the exercise of stock options under the company's Employees’ Stock Option Scheme 2017. Consequently, the company's paid-up share capital has increased to ₹10,25,63,858. The total share count now includes 5,12,77,899 fully paid equity shares and 8,060 partly paid shares.

Allotment of 37,385 equity shares of face value ₹2 each under ESOP 2017
Paid-up share capital increased to ₹10,25,63,858 post-allotment
Total fully paid equity shares stand at 5,12,77,899
New shares will rank pari-passu with existing equity shares

💡 This is a routine administrative update involving minor equity dilution. Investors should continue to monitor the company's core business performance as this allotment has no material impact on valuation.

Navin Fluorine: TDS Certificates for FY 2025-26 Interim Dividend Now Available

🟡 NEUTRAL ⭐ 3/10

DIVIDEND 📅 08 Apr 2026, 06:40 PM

Navin Fluorine International Limited has notified shareholders regarding the availability of TDS certificates for the interim dividend paid on November 27, 2025. Shareholders who had tax deducted at source can download Form 16A from the KFin Technologies portal. This facility is part of the standard tax compliance process for the dividend declared during the October 30, 2025, board meeting. The certificates will be available for online download until October 31, 2026.

Interim dividend for FY 2025-26 was paid to eligible shareholders on November 27, 2025.
TDS certificates (Form 16A) are available for download via KFin Technologies' dedicated portal.
The online download link for these certificates will remain active until October 31, 2026.
Shareholders can also verify tax credits through Form 26AS on the Income Tax e-filing website.

💡 Shareholders who received the interim dividend and were subject to TDS should download Form 16A for their tax records. No action is required for investors whose dividend income was below the taxable threshold.

Navin Fluorine Promoters Declare Zero Share Encumbrance for FY 2025-26

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 08 Apr 2026, 03:29 PM

Vishad P. Mafatlal, on behalf of the promoter group of Navin Fluorine International Limited, has issued a formal declaration under SEBI Takeover Regulations. The disclosure confirms that the promoters and persons acting in concert have not created any encumbrance or pledge on their equity shares during the financial year 2025-2026. This is a routine annual compliance filing required by SEBI to ensure transparency in promoter holdings. The absence of share pledges is generally viewed as a sign of financial stability within the promoter group.

Declaration submitted under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Promoters and persons acting in concert (PAC) reported zero encumbrances on equity shares for FY 2025-26
The disclosure was formally submitted to both BSE and NSE on April 01, 2026
A copy of the declaration has been provided to the Audit Committee of the Company

💡 No action is required as this is a routine regulatory filing confirming that promoter shares remain unencumbered. Investors should maintain their existing outlook on the company's fundamentals.

Navin Fluorine Assigned ESG Rating Score of 67 by NSE Sustainability

🟡 NEUTRAL ⭐ 4/10

OTHER 📅 03 Apr 2026, 12:25 PM

Navin Fluorine International Limited has been assigned an ESG Rating score of 67 by NSE Sustainability Ratings and Analytics Limited. The rating is based on data available in the public domain for the fiscal year 2024-2025. Notably, the company did not engage the agency for this rating, making it an independent assessment. Such ratings are increasingly used by institutional investors to gauge corporate governance and sustainability standards.

NSE Sustainability Ratings assigned an ESG score of 67 to the company
The rating assessment is based on public data for the 2024-2025 fiscal year
The company did not formally engage or commission NSE Sustainability for this report
Disclosure made under Regulation 30 of SEBI Listing Regulations

💡 Investors should view this as a routine disclosure that reflects the company's standing in sustainability metrics; no immediate portfolio changes are recommended based on this independent rating.

Navin Fluorine Board to Meet April 29 for FY26 Results and Final Dividend Recommendation

🟡 NEUTRAL ⭐ 4/10

BOARD_MEETING 📅 26 Mar 2026, 03:42 PM

Navin Fluorine International Limited has scheduled a Board Meeting on April 29, 2026, to approve the audited standalone and consolidated financial results for the fiscal year ending March 31, 2026. The board will also consider recommending a final dividend for the financial year 2025-2026. In compliance with SEBI insider trading regulations, the trading window for the company's securities will be closed from March 31, 2026, to May 1, 2026. This is a routine regulatory filing that precedes the annual earnings announcement.

Board meeting scheduled for April 29, 2026, to approve FY26 annual audited results.
The board will consider and recommend a final dividend for the financial year 2025-2026.
Trading window closure period set from March 31, 2026, to May 1, 2026, inclusive.
The results will encompass both standalone and consolidated financial performance for the year ending March 31, 2026.

💡 Investors should monitor the April 29 results for updates on specialty chemical margins and the final dividend payout ratio. No immediate action is required as this is a standard regulatory notification.

Navin Fluorine Promoters Release Pledge on 1.5 Lakh Shares; Now 100% Pledge-Free

🟢 POSITIVE ⭐ 6/10

REGULATORY 📅 24 Mar 2026, 03:51 PM

Mafatlal Impex Private Limited, a promoter group entity of Navin Fluorine International Limited, has released a pledge on 1,50,000 equity shares. These shares, representing 0.29% of the company, were previously pledged with State Bank of India. Following this release, the entire promoter holding of 25.44% (1,30,36,149 shares) is now completely free of any encumbrances. This move eliminates the risk of forced liquidation by lenders and reflects improved financial health of the promoter group.

Release of pledge on 1,50,000 equity shares (0.29% stake) by promoter Mafatlal Impex Private Limited.
The shares were released by State Bank of India (SBI) on March 20, 2026.
The notional value of the released shares is approximately ₹91.86 crore based on recent market prices.
Post-transaction, 100% of the promoter's total 25.44% stake in the company is now unencumbered.
The Amended and Restated Agreement for Pledge dated August 14, 2024, has officially terminated.

💡 Investors should view the transition to a zero-pledge status as a positive indicator of promoter stability. While this improves market sentiment, long-term focus should remain on the company's execution in the specialty chemicals and CDMO segments.

Navin Fluorine Promoters Release All Pledged Shares; 1.5 Lakh Shares Unpledged by SBI

🟢 POSITIVE ⭐ 6/10

ROUTINE 📅 23 Mar 2026, 05:13 PM

Navin Fluorine's promoter, Mafatlal Impex Private Limited, has successfully released the remaining 1,50,000 pledged equity shares from State Bank of India. This follows a previous release of 3,00,000 shares, effectively bringing the total number of pledged promoter shares to zero. The termination of the pledge agreement dated August 14, 2024, signifies that the promoter's entire holding is now encumbrance-free. This move is generally viewed as a positive signal regarding the financial health and stability of the promoter group.

Release of final 1,50,000 equity shares of face value ₹2 each previously pledged to SBI
Promoter group equity shares in the company are now 100% free of any pledge
Automatic termination of the Amended and Restated Agreement for Pledge dated August 14, 2024
Follows a prior release of 3,00,000 shares as per the August 22, 2024, disclosure

💡 Investors should view this as a positive corporate governance development that removes potential liquidation risk. No immediate action is required, but the zero-pledge status strengthens the stock's investment profile.

Navin Fluorine Q3 FY26 PAT Jumps 122% to ₹185 Cr; Revenue Up 47% YoY

🟢 POSITIVE ⭐ 9/10

EARNINGS 📅 13 Feb 2026, 11:19 AM

Navin Fluorine reported a stellar Q3 FY26 performance with revenue growing 47% YoY to ₹892 crores, driven by strong growth across all business verticals. The company's EBITDA margins expanded significantly to 34.5%, up from 24.3% in the previous year, reflecting strong operating leverage and better realizations. Notably, the Specialty Chemicals segment achieved its highest-ever quarterly revenue of ₹354 crores, while the CDMO business grew by 61% YoY. With the successful commissioning of Wave-1 CAPEX projects and a healthy pipeline for Wave-2, the company remains well-positioned for sustainable growth.

Consolidated Revenue for Q3 FY26 rose 47% YoY to ₹892 crores, surpassing full-year FY25 revenue within nine months.
Net Profit (PAT) surged 122% YoY to ₹185 crores, with EBITDA margins expanding by 1,020 bps to 34.5%.
Specialty Chemicals vertical recorded its highest-ever quarterly revenue of ₹354 crores, a 60% YoY increase.
Successfully commissioned cGMP-4 Phase-1 and AHF projects, marking the completion of Wave-1 CAPEX.
Maintained a strong balance sheet with a net debt-to-equity ratio of 0.03x and working capital below 80 days.

💡 Investors should view this as a strong growth signal given the massive margin expansion and successful execution of CAPEX projects. The stock remains a high-conviction play in the specialty fluorochemicals and CDMO space with clear revenue visibility.

Navin Fluorine Q3FY26: Revenue up 47% YoY to ₹892 Cr, EBITDA jumps 109%

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 10 Feb 2026, 06:29 PM

Navin Fluorine reported a robust Q3FY26 with consolidated revenue growing 47% YoY to ₹892.4 crore. Operating EBITDA saw a significant surge of 109% YoY to ₹307.6 crore, with margins expanding by 1017 bps to 34.5%. Growth was driven by strong performance across Specialty Chemicals (+60% YoY), CDMO (+61% YoY), and HPP (+35% YoY) segments. The company is also progressing on several capex projects, including HFC expansion and MPP de-bottlenecking, aimed at future growth.

Consolidated Revenue for Q3FY26 grew 47% YoY to ₹892.4 crore and 18% Q-o-Q.
Operating EBITDA margin expanded significantly to 34.5%, up from 24.3% in the previous year.
Specialty Chemicals revenue reached its highest-ever quarter at ₹354 crore, up 60% YoY.
CDMO business grew 61% YoY to ₹127 crore with strong order visibility for CY26 and beyond.
Announced ₹236.5 crore capex for additional HFC capacity (R32) with a peak revenue potential of ₹600-825 crore.

💡 Investors should note the significant margin expansion and strong performance across all three business verticals. The stock remains a key play in the fluorination space with visible growth from upcoming capex in HFC and Specialty Chemicals.

Navin Fluorine Q3FY26: Revenue Jumps 47% to ₹892 Cr, EBITDA Surges 109% with Strong Margins

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 10 Feb 2026, 05:32 PM

Navin Fluorine reported a robust Q3FY26 performance with consolidated revenue growing 47% YoY to ₹892.4 crore and Operating EBITDA surging 109% YoY to ₹307.6 crore. Operating EBITDA margins expanded significantly by 1017 bps YoY to 34.5%, driven by higher realizations and volumes across Specialty and HPP segments. The company is executing major capex projects, including a ₹236.5 crore HFC expansion and a ₹75 crore de-bottlenecking project, both targeted for Q3FY27. The CDMO business also showed strong momentum with 61% YoY growth and a positive outlook for CY26.

Consolidated Q3FY26 Revenue grew 47% YoY to ₹892.4 Cr; Operating EBITDA rose 109% to ₹307.6 Cr.
Operating EBITDA margin reached 34.5%, up 1017 bps YoY and 201 bps Q-o-Q.
Specialty Chemicals segment achieved its highest-ever quarterly revenue of ₹354 Cr, up 60% YoY.
New HFC capacity capex of ₹236.5 Cr is on track for Q3FY27 with a peak revenue potential of ₹600-825 Cr.
CDMO segment revenue increased 61% YoY to ₹127 Cr with strong order visibility from European majors.

💡 Investors should take note of the significant margin expansion and the aggressive capex roadmap which provides high revenue visibility through FY27. The stock remains a strong candidate for long-term portfolios focused on the specialty chemicals and CDMO sectors.

Navin Fluorine Releases Q3 FY26 Earnings Call Audio Recording

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 09 Feb 2026, 08:15 PM

Navin Fluorine International Limited has made the audio recording of its Q3 FY 2025-26 earnings call available to the public. The call, held on February 09, 2026, discussed the company's operational and financial performance for the quarter ended December 31, 2025. This is a standard regulatory disclosure under SEBI LODR Regulations to ensure transparency for all shareholders. Investors can access the full recording via the link provided on the company's official website.

Audio recording of the earnings call for Q3 FY 2025-26 is now available online.
The call was held on February 09, 2026, following the announcement of quarterly results.
Management discussed operational and financial performance for the period ending December 31, 2025.
The disclosure complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

💡 Investors should listen to the recording to gain insights into management's commentary on margin trends and the progress of new capital expenditure projects. No immediate action is required as this is a routine disclosure.

Navin Fluorine Q3 FY26: Revenue up 47% YoY to ₹892 Cr, EBITDA Margins Expand to 34.5%

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 09 Feb 2026, 05:10 PM

Navin Fluorine reported a robust Q3 FY26 with consolidated revenue growing 47% YoY to ₹892.4 crore, driven by strong performance across all business verticals. Operating EBITDA surged 109% YoY to ₹307.6 crore, with margins expanding significantly by 1017 bps to 34.5%. The Specialty Chemicals segment achieved its highest-ever quarterly revenue of ₹354 crore, while the CDMO and HPP segments grew by 61% and 35% respectively. The company is aggressively investing in capex, including a ₹236.5 crore HFC expansion and ₹75 crore MPP de-bottlenecking, both targeted for Q3 FY27.

Consolidated Revenue grew 47% YoY to ₹892.4 Cr; PAT increased 122% YoY to ₹185.4 Cr.
Operating EBITDA margin expanded significantly to 34.5% from 24.3% in the previous year.
Specialty Chemicals segment recorded its highest-ever quarterly revenue of ₹354 Cr, up 60% YoY.
CDMO business showed strong momentum with 61% YoY growth and robust order visibility for Q4 and beyond.
Announced HFC (R32) capex of ₹236.5 Cr with a peak revenue potential of ₹600-825 Cr per annum.

💡 Investors should consider this a strong performance update, highlighting successful execution in high-margin segments and clear visibility for future growth through massive capex. The significant margin expansion and 'highest-ever' specialty revenue suggest a structural improvement in profitability.

Navin Fluorine CHRO Pankaj Lochan Resigns Effective February 27, 2026

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 09 Feb 2026, 05:01 PM

Navin Fluorine International Limited has announced the resignation of Mr. Pankaj Lochan from the position of Chief Human Resource Officer (CHRO). His resignation will be effective from the close of business hours on February 27, 2026. The departure is attributed to his personal and professional plans. The company has already initiated a search for a suitable senior professional to fill this key leadership role.

Mr. Pankaj Lochan to step down as Chief Human Resource Officer on February 27, 2026
Resignation is driven by personal and professional plans according to the official filing
The company has formally initiated a search for a successor for the CHRO position
Transition period of approximately 18 days provided from the date of announcement (Feb 9 to Feb 27)

💡 This is a routine management change at the functional head level and does not warrant immediate action. Investors should monitor if there are further exits in the senior leadership team which could signal organizational instability.

Navin Fluorine CHRO Pankaj Lochan Resigns Effective February 27, 2026

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 09 Feb 2026, 04:56 PM

Mr. Pankaj Lochan, the Chief Human Resource Officer (CHRO) of Navin Fluorine International Limited, has tendered his resignation effective February 27, 2026. The departure is attributed to his personal and professional plans, and the company has already initiated a search for a suitable senior professional to fill the role. This transition follows a formal notice period starting from February 9, 2026, to ensure a smooth handover of responsibilities. While senior management changes are important, the CHRO role is typically less impactful on immediate financial performance than CEO or CFO transitions.

Mr. Pankaj Lochan to step down as Chief Human Resource Officer effective February 27, 2026
Resignation letter submitted on February 9, 2026, citing personal and professional plans
Company has initiated a search for a new senior professional for the CHRO position
Transition period of approximately 18 days provided to ensure smooth handover of duties

💡 This is a routine management change and requires no immediate action; however, investors should monitor for any further senior-level exits that could suggest broader organizational instability.

View All NAVINFLUOR Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue for H1 FY26 rose 42% to INR 1,484 Cr. Q2 FY26 revenue grew 46% to INR 758 Cr. The High-Performance Products (HPP) segment achieved 38% YoY growth in Q2 FY26, crossing INR 400 Cr. In FY23, high-value segments (Specialty Chemicals and CDMO) grew 30% YoY, though they saw a decline of 30% and 13% respectively in FY24 due to industry headwinds.

Geographic Revenue Split

Exports accounted for 56% of total revenue in FY25. Key international markets include North America, Europe, the Middle East, and Asia Pacific, while the remaining 44% is derived from domestic Indian operations.

Profitability Margins

Operating margins have shown volatility; PBILDT margin improved from 24.4% in FY22 to 26.6% in FY23, but moderated to 19.40% in FY24 and 19.16% in Q1 FY25 due to pricing pressures in export refrigerants and a shift in business mix. Gross profit margins remained stable in Q2 FY26, with earnings growth driven by operating leverage.

EBITDA Margin

EBITDA for H1 FY26 more than doubled compared to H1 FY25. The company faces a negative rating trigger if PBILDT margins fall below 20% on a sustained basis, while a positive trigger is set for achieving an operating ROCE above 28%.

Capital Expenditure

The company is executing large-sized, partly debt-funded projects. A Qualified Institutional Placement (QIP) of INR 750 Cr was completed in July 2025, primarily to reduce debt in its subsidiary, Navin Fluorine Advanced Sciences Limited (NFASL), and support ongoing value-accretive capex expected to drive growth beyond FY27.

Credit Rating & Borrowing

Long-term bank facilities of INR 210.10 Cr are rated CARE AA; Stable (reaffirmed Sept 2025). Short-term facilities of INR 230.10 Cr are rated CARE A1+. Borrowing costs are supported by a strong financial risk profile with a net debt-to-equity ratio of 0.9x as of September 30, 2025.

⚙️ Operational Drivers

Raw Materials

Key raw materials include Fluorspar (accounting for over 40% of total raw material costs), Chloroform, and Sulphur.

Import Sources

Fluorspar is primarily sourced from South Africa and China. The company has specifically entered long-term contracts with South African miners to de-risk its supply chain from Chinese volatility.

Key Suppliers

Not disclosed in available documents beyond general references to South African miners.

Capacity Expansion

The company operates a Multipurpose Plant (MPP) and is focusing on debottlenecking to drive higher asset sweating. Dedicated capex for specific molecules is considered as volumes scale. New projects in the NFASL subsidiary have recently commenced operations to expand the fluorine value chain.

Raw Material Costs

Raw material costs are highly volatile, particularly Fluorspar. While the company has historically passed on cost increases to customers, there is a time lag that can temporarily squeeze margins.

Manufacturing Efficiency

Efficiency is driven by operating leverage, as seen in Q2 FY26 where revenue grew 46% while operating costs increased only 12%.

📈 Strategic Growth

Expected Growth Rate

42%

Growth Strategy

Growth is targeted through a focus on high-value CDMO and Specialty Chemical verticals, leveraging R&D in complex fluorine chemistry. The company is utilizing a 'Navin Molecular' brand to expand CDMO services beyond fluorination and has secured multi-year contracts with global innovators to ensure revenue visibility.

Products & Services

Refrigerant gases (including R32 and HFOs), inorganic fluorides, specialty fluorides, and CDMO services for pharmaceutical and agrochemical intermediates.

Brand Portfolio

MAFRON (refrigerant gases), Navin Molecular (CDMO business).

New Products/Services

Expansion into HFO (Hydrofluoroolefins) and R32 refrigeration gases to replace older HCFC products; new product pipelines in R&D are expected to accelerate growth from FY27 onwards.

Market Expansion

Targeting growth in North America and Europe through the CDMO vertical and high-performance products.

Market Share & Ranking

One of the largest specialty fluorochemical companies in India and a pioneer in refrigerant gas manufacturing.

Strategic Alliances

Strategic multi-year partnerships with global players for supplying intermediates in the pharma and agrochemical industries.

🌍 External Factors

Industry Trends

The industry is shifting toward low-GWP (Global Warming Potential) refrigerants like HFOs due to environmental regulations. Navin is positioning itself by increasing the share of high-value specialty chemicals and CDMO services which are less commoditized.

Competitive Landscape

Faces competition in certain business segments and pricing pressure in the export market for refrigerant gases.

Competitive Moat

Moat is built on complex fluorine chemistry expertise, R&D capabilities, and long-standing relationships with global innovators. These are sustainable due to the high technical barriers and hazardous nature of fluorine handling.

Macro Economic Sensitivity

Sensitive to global pharmaceutical and agrochemical demand cycles, as these end-user industries drive the CDMO and Specialty Chemical segments.

Consumer Behavior

Increasing demand for sustainable and 'Responsible Care' certified chemical suppliers among global pharmaceutical and agrochemical majors.

Geopolitical Risks

Exposure to trade barriers and supply chain disruptions due to the high percentage of exports and reliance on imported Fluorspar.

⚖️ Regulatory & Governance

Industry Regulations

Subject to environmental norms regarding the production and phase-out of ozone-depleting substances (HCFCs) and manufacturing standards for hazardous chemicals.

Environmental Compliance

The company holds 'Responsible Care' certification and has released its third sustainability report in 2025. It faces risks from the regulatory phase-out of HCFCs.

Legal Contingencies

Secretarial Audit Reports for FY25 for NFIL and its material subsidiary NFASL contained no qualifications, reservations, or adverse remarks.

⚠️ Risk Analysis

Key Uncertainties

Volatility in Fluorspar prices (40% of RM cost) and potential delays in realizing returns from large-scale capex projects (ROCE target >14% to avoid rating downgrade).